Patents by Inventor Paul Mikus
Paul Mikus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250230556Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis products to a site which may be used for treatment of infection and ablation of undesirable cells and tissue. A system disclosed may include a power supply, two electrodes, an aqueous matrix that may close the electric circuit between the electrodes at the treated site, and a controller. The controller may control the electrical circuit to induce a direct current through the electrodes and an aqueous matrix to produce electrolysis products. The duration and magnitude of the charge applied may determine the dose of the products applied to the treatment site. The composition of the electrodes and the aqueous matrix may be chosen to produce desired products. An apparatus is disclosed that may be in the form of a pad for applying to a wound. An apparatus is disclosed that may be used for treating internal tissue.Type: ApplicationFiled: December 18, 2024Publication date: July 17, 2025Applicant: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Publication number: 20250195128Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A pulse that has an element of decay may be applied to a target for tissue ablation while the decay is modulated. In some examples, apparatus including a controller and switches may be used to modulate the decay and/or selectively apply the pulse to the target. The apparatus may further include resistors and/or other elements to modulate a magnitude of the pulse and/or a slope of a decay of the pulse.Type: ApplicationFiled: October 28, 2024Publication date: June 19, 2025Applicant: Inter Science GmbHInventors: Enric Günther, Boris Rubinsky, Nina Klein, Paul Mikus, Michael Stehling
-
Patent number: 12209318Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis products to a site which may be used for treatment of infection and ablation of undesirable cells and tissue. A system disclosed may include a power supply, two electrodes, an aqueous matrix that may close the electric circuit between the electrodes at the treated site, and a controller. The controller may control the electrical circuit to induce a direct current through the electrodes and an aqueous matrix to produce electrolysis products. The duration and magnitude of the charge applied may determine the dose of the products applied to the treatment site. The composition of the electrodes and the aqueous matrix may be chosen to produce desired products. An apparatus is disclosed that may be in the form of a pad for applying to a wound. An apparatus is disclosed that may be used for treating internal tissue.Type: GrantFiled: December 16, 2021Date of Patent: January 28, 2025Assignee: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Patent number: 12127779Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A pulse that has an element of decay may be applied to a target for tissue ablation while the decay is modulated. In some examples, apparatus including a controller and switches may be used to modulate the decay and/or selectively apply the pulse to the target. The apparatus may further include resistors and/or other elements to modulate a magnitude of the pulse and/or a slope of a decay of the pulse.Type: GrantFiled: September 4, 2019Date of Patent: October 29, 2024Assignee: Inter Science GmbHInventors: Enric Günther, Boris Rubinsky, Nina Klein, Paul Mikus, Michael Stehling
-
Patent number: 12011190Abstract: An elongate ultrasonic dissector-shaver probe has a laterally enlarged head extending distally and transversely from a distal end of a shaft and provided with sets of spiraling ribs. In a disc space preparation procedure, the probe is inserted into a spinal disc between two vertebral endplates, ultrasonic vibratory energy is conducted into the probe, and the probe is manipulated to move the laterally enlarged head in three spatial directions within the spinal disc to thereby disrupt and shred the spinal disc material into fragments extracted from the space, in part by suction and in part by using forceps to pull spinal disc fragments from the operative space or surgical site between the vertebral endplates.Type: GrantFiled: May 21, 2021Date of Patent: June 18, 2024Assignee: Misonix, LLCInventors: Nicholas Theodore, Dan Voic, Paul Mikus, Christopher Ballor, Sharon Klugewicz
-
Publication number: 20240065749Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: ApplicationFiled: November 6, 2023Publication date: February 29, 2024Applicants: Inter Science GmbH, RM2 Technology LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther
-
Patent number: 11866833Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis treatment and cellular permeabilization treatment to a site in tissue. A system disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through the aqueous matrix to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site. The composition of the electrodes may be chosen in accordance with the desired products produced and electroporation effects. An apparatus is disclosed that may be in the form of electrodes for electrolysis and electrodes for electroporation applied to the tissue. An apparatus is disclosed that may be used for treating internal tissue.Type: GrantFiled: April 2, 2021Date of Patent: January 9, 2024Assignee: RM2 Technology LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Patent number: 11857244Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: GrantFiled: March 8, 2021Date of Patent: January 2, 2024Assignees: Inter Science GmbH, RM2 Technology LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther
-
Patent number: 11839390Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: April 13, 2021Date of Patent: December 12, 2023Assignee: MISONIX, LLCInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Patent number: 11737775Abstract: A surgical system for transecting osseous tissue includes an ultrasonic waveform generator, a control unit, an ultrasonic instrument assembly including a electromechanical transducer and an ultrasonic blade, and a robotic system. The ultrasonic instrument assembly is attached to the robotic arm. The surgical system is configured so that the robotic arm moves the ultrasonic blade at a constant forward feed speed through the bone during a cutting operation and so that the forward motion is reduced, and preferably halted automatically upon a reduction in load per unit time or applied power, as monitored by a pickup or sensor.Type: GrantFiled: November 16, 2020Date of Patent: August 29, 2023Assignee: MISONIX, LLCInventors: Dan Voic, Paul Mikus
-
Patent number: 11389183Abstract: An ultrasonic surgical probe has an elongate shaft and a probe head that is enlarged to extend laterally or transversely in two opposed directions relative to the shaft The head is formed with a recess or cavity facing laterally in a third direction relative to the shaft and the axis. Where the head lies in a plane, owing to its lateral enlargement or extension, the recess or cavity faces in a direction perpendicular to that plane. The recess or cavity is defined in part by an inclined floor or base surface contiguous at a proximal end with the shaft. The recess or cavity is defined in part by a peripheral wall extending only partway around the recess or cavity, along a distal side and two lateral sides thereof. The cavity or recess is closed on a proximal side by the inclined surface and the shaft.Type: GrantFiled: September 17, 2019Date of Patent: July 19, 2022Assignee: MISONIX, LLCInventors: Dan Voic, Scott Isola, Paul Mikus
-
Patent number: 11324531Abstract: A medical drill assembly includes a probe connectable at a proximal end to an electromechanical transducer for generating mechanical vibration of an ultrasonic frequency. The probe has a shaft with a central lumen or channel, the shaft being formed at a distal end with a head having a tapered distal side. A source of pressurized liquid communicates with the lumen or channel of the probe, and a translatory or linear drive is operatively connected to the probe for applying a distally directed force to the probe. A controller is operatively connected to the translatory or linear drive for periodically at least reducing the magnitude of the distally directed force.Type: GrantFiled: April 18, 2019Date of Patent: May 10, 2022Assignee: MISONIX, INCORPORATEDInventors: Dan Voic, Paul Mikus
-
Publication number: 20220105256Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis products to a site which may be used for treatment of infection and ablation of undesirable cells and tissue. A system disclosed may include a power supply, two electrodes, an aqueous matrix that may close the electric circuit between the electrodes at the treated site, and a controller. The controller may control the electrical circuit to induce a direct current through the electrodes and an aqueous matrix to produce electrolysis products. The duration and magnitude of the charge applied may determine the dose of the products applied to the treatment site. The composition of the electrodes and the aqueous matrix may be chosen to produce desired products. An apparatus is disclosed that may be in the form of a pad for applying to a wound. An apparatus is disclosed that may be used for treating internal tissue.Type: ApplicationFiled: December 16, 2021Publication date: April 7, 2022Applicant: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Patent number: 11260165Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis products to a site which may be used for treatment of infection and ablation of undesirable cells and tissue. A system disclosed may include a power supply, two electrodes, an aqueous matrix that may close the electric circuit between the electrodes at the treated site, and a controller. The controller may control the electrical circuit to induce a direct current through the electrodes and an aqueous matrix to produce electrolysis products. The duration and magnitude of the charge applied may determine the dose of the products applied to the treatment site. The composition of the electrodes and the aqueous matrix may be chosen to produce desired products. An apparatus is disclosed that may be in the form of a pad for applying to a wound. An apparatus is disclosed that may be used for treating internal tissue.Type: GrantFiled: December 13, 2018Date of Patent: March 1, 2022Assignee: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Patent number: 11229734Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis products to a site which may be used for treatment of infection and ablation of undesirable cells and tissue. A system disclosed may include a power supply, two electrodes, an aqueous matrix that may close the electric circuit between the electrodes at the treated site, and a controller. The controller may control the electrical circuit to induce a direct current through the electrodes and an aqueous matrix to produce electrolysis products. The duration and magnitude of the charge applied may determine the dose of the products applied to the treatment site. The composition of the electrodes and the aqueous matrix may be chosen to produce desired products. An apparatus is disclosed that may be in the form of a pad for applying to a wound. An apparatus is disclosed that may be used for treating internal tissue.Type: GrantFiled: December 13, 2018Date of Patent: January 25, 2022Assignee: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Publication number: 20210330371Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A pulse that has an element of decay may be applied to a target for tissue ablation while the decay is modulated. In some examples, apparatus including a controller and switches may be used to modulate the decay and/or selectively apply the pulse to the target. The apparatus may further include resistors and/or other elements to modulate a magnitude of the pulse and/or a slope of a decay of the pulse.Type: ApplicationFiled: September 4, 2019Publication date: October 28, 2021Applicant: Inter Science GmbHInventors: Enric Günther, Boris Rubinsky, Nina Klein, Paul Mikus, Michael Stehling
-
Patent number: 11147570Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: February 6, 2019Date of Patent: October 19, 2021Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Patent number: 11123475Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis treatment and cellular permeabilization treatment to a site in tissue. A system disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through the aqueous matrix to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site. The composition of the electrodes may be chosen in accordance with the desired products produced and electroporation effects. An apparatus is disclosed that may be in the form of electrodes for electrolysis and electrodes for electroporation applied to the tissue. An apparatus is disclosed that may be used for treating internal tissue.Type: GrantFiled: July 11, 2019Date of Patent: September 21, 2021Assignee: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Publication number: 20210220532Abstract: Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis treatment and cellular permeabilization treatment to a site in tissue. A system disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through the aqueous matrix to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site. The composition of the electrodes may be chosen in accordance with the desired products produced and electroporation effects. An apparatus is disclosed that may be in the form of electrodes for electrolysis and electrodes for electroporation applied to the tissue. An apparatus is disclosed that may be used for treating internal tissue.Type: ApplicationFiled: April 2, 2021Publication date: July 22, 2021Applicant: RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky
-
Publication number: 20210186592Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: ApplicationFiled: March 8, 2021Publication date: June 24, 2021Applicants: INTER SCIENCE GMBH, RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther